167 related articles for article (PubMed ID: 32782394)
21.
Bi L; Liu Y; Yang Q; Zhou X; Li H; Liu Y; Li J; Lu Y; Tang H
Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33537802
[No Abstract] [Full Text] [Related]
22. Glutamine synthetase functions as a negative growth regulator in glioma.
Yin Y; Sun W; Xiang J; Deng L; Zhang B; Xie P; Qiao W; Zou J; Liu C
J Neurooncol; 2013 Aug; 114(1):59-69. PubMed ID: 23780646
[TBL] [Abstract][Full Text] [Related]
23. The anti-proliferative effect of L-carnosine correlates with a decreased expression of hypoxia inducible factor 1 alpha in human colon cancer cells.
Iovine B; Oliviero G; Garofalo M; Orefice M; Nocella F; Borbone N; Piccialli V; Centore R; Mazzone M; Piccialli G; Bevilacqua MA
PLoS One; 2014; 9(5):e96755. PubMed ID: 24804733
[TBL] [Abstract][Full Text] [Related]
24. L-Carnosine Prevents the Pro-cancerogenic Activity of Senescent Peritoneal Mesothelium Towards Ovarian Cancer Cells.
Mikuła-Pietrasik J; Książek K
Anticancer Res; 2016 Feb; 36(2):665-71. PubMed ID: 26851022
[TBL] [Abstract][Full Text] [Related]
25. Procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 promotes hypoxia-induced glioma migration and invasion.
Xu Y; Zhang L; Wei Y; Zhang X; Xu R; Han M; Huang B; Chen A; Li W; Zhang Q; Li G; Wang J; Zhao P; Li X
Oncotarget; 2017 Apr; 8(14):23401-23413. PubMed ID: 28423580
[TBL] [Abstract][Full Text] [Related]
26. Effects of Long Form of CAPON Overexpression on Glioma Cell Proliferation are Dependent on AKT/mTOR/P53 Signaling.
Liang D; Song Y; Fan G; Ji D; Zhang T; Nie E; Liu X; Liang J; Yu R; Gao S
Int J Med Sci; 2019; 16(4):614-622. PubMed ID: 31171914
[No Abstract] [Full Text] [Related]
27. Proteasome inhibition with bortezomib induces cell death in GBM stem-like cells and temozolomide-resistant glioma cell lines, but stimulates GBM stem-like cells' VEGF production and angiogenesis.
Bota DA; Alexandru D; Keir ST; Bigner D; Vredenburgh J; Friedman HS
J Neurosurg; 2013 Dec; 119(6):1415-23. PubMed ID: 24093630
[TBL] [Abstract][Full Text] [Related]
28. Shikonin Inhibits the Migration and Invasion of Human Glioblastoma Cells by Targeting Phosphorylated β-Catenin and Phosphorylated PI3K/Akt: A Potential Mechanism for the Anti-Glioma Efficacy of a Traditional Chinese Herbal Medicine.
Zhang FY; Hu Y; Que ZY; Wang P; Liu YH; Wang ZH; Xue YX
Int J Mol Sci; 2015 Oct; 16(10):23823-48. PubMed ID: 26473829
[TBL] [Abstract][Full Text] [Related]
29. ERN1 dependent impact of glucose and glutamine deprivations on PBX3, PBXIP1, PAX6, MEIS1, and MEIS2 genes expression in U87 glioma cells.
Krasnytska DO; Viletska YM; Minchenko DO; Khita OO; Tsymbal DO; Cherednychenko AA; Kozynkevych HE; Oksiom NS; Minchenko OH
Endocr Regul; 2023 Jan; 57(1):37-47. PubMed ID: 36753664
[No Abstract] [Full Text] [Related]
30. Causes and Consequences of A Glutamine Induced Normoxic HIF1 Activity for the Tumor Metabolism.
Kappler M; Pabst U; Weinholdt C; Taubert H; Rot S; Kaune T; Kotrba J; Porsch M; Güttler A; Bache M; Krohn K; Bull F; Riemann A; Wickenhauser C; Seliger B; Schubert J; Al-Nawas B; Thews O; Grosse I; Vordermark D; Eckert AW
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31554283
[TBL] [Abstract][Full Text] [Related]
31. β-asarone induces cell apoptosis, inhibits cell proliferation and decreases migration and invasion of glioma cells.
Wang N; Han Y; Luo L; Zhang Q; Ning B; Fang Y
Biomed Pharmacother; 2018 Oct; 106():655-664. PubMed ID: 29990855
[TBL] [Abstract][Full Text] [Related]
32. Resveratrol increases glutamate uptake and glutamine synthetase activity in C6 glioma cells.
dos Santos AQ; Nardin P; Funchal C; de Almeida LM; Jacques-Silva MC; Wofchuk ST; Gonçalves CA; Gottfried C
Arch Biochem Biophys; 2006 Sep; 453(2):161-7. PubMed ID: 16904623
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of tumour cell growth by carnosine: some possible mechanisms.
Hipkiss AR; Gaunitz F
Amino Acids; 2014 Feb; 46(2):327-37. PubMed ID: 24292217
[TBL] [Abstract][Full Text] [Related]
34. Ovarian cancer therapeutic potential of glutamine depletion based on GS expression.
Furusawa A; Miyamoto M; Takano M; Tsuda H; Song YS; Aoki D; Miyasaka N; Inazawa J; Inoue J
Carcinogenesis; 2018 May; 39(6):758-766. PubMed ID: 29617730
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-588 regulates the invasive, migratory and vasculogenic mimicry-forming abilities of hypoxic glioma cells by targeting ROBO1.
Yu R; Zhao R; Sun X; Zhang Z; Wang S; Gao X; Sun Z; Xue H; Li G
Mol Biol Rep; 2023 Feb; 50(2):1333-1347. PubMed ID: 36459288
[TBL] [Abstract][Full Text] [Related]
36. [Effects of FPR2 gene silencing on the proliferation, migration and invasion of human glioma U87 cells].
Liu L; Li X; Shi J; Li L; Wang J; Luo ZZ
Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):659-666. PubMed ID: 30293389
[No Abstract] [Full Text] [Related]
37. ERN1 knockdown modifies the impact of glucose and glutamine deprivations on the expression of EDN1 and its receptors in glioma cells.
Minchenko DO; Khita OO; Tsymbal DO; Viletska YM; Sliusar MY; Yefimova YV; Levadna LO; Krasnytska DA; Minchenko OH
Endocr Regul; 2021 May; 55(2):72-82. PubMed ID: 34020533
[No Abstract] [Full Text] [Related]
38. Endogenous glutamine is rate-limiting for anti-CD3 and anti-CD28 induced CD4+ T-cell proliferation and glycolytic activity under hypoxia and normoxia.
Wik JA; Chowdhury A; Kolan S; Bastani NE; Li G; Alam K; Grimolizzi F; Skålhegg BS
Biochem J; 2022 Jun; 479(11):1221-1235. PubMed ID: 35695514
[TBL] [Abstract][Full Text] [Related]
39. Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target.
Bolzoni M; Chiu M; Accardi F; Vescovini R; Airoldi I; Storti P; Todoerti K; Agnelli L; Missale G; Andreoli R; Bianchi MG; Allegri M; Barilli A; Nicolini F; Cavalli A; Costa F; Marchica V; Toscani D; Mancini C; Martella E; Dall'Asta V; Donofrio G; Aversa F; Bussolati O; Giuliani N
Blood; 2016 Aug; 128(5):667-79. PubMed ID: 27268090
[TBL] [Abstract][Full Text] [Related]
40. Oleuropein inhibits the proliferation and invasion of glioma cells via suppression of the AKT signaling pathway.
Liu M; Wang J; Huang B; Chen A; Li X
Oncol Rep; 2016 Oct; 36(4):2009-16. PubMed ID: 27498673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
